Outcomes of reduced dosing of lenvatinib with pembrolizumab for advanced endometrial cancer

被引：0
|
作者：
Quang Dang Ta
Do, Connie
Sharma, Kavita
Sorooshian, Hormozan
Cushing, Merta
Shah, Nina
Bookman, Michael A.
Kavecansky, Juraj
Niu, Fang
Hui, Rita L.
机构：
[1] Kaiser Permanente, Walnut Creek, CA USA
[2] Kaiser Permanente San Diego, San Diego, CA USA
[3] Kaiser Permanente, Roseville, CA USA
[4] Kaiser Permanente, San Diego, CA USA
[5] Kaiser Permanente Natl Drug Use Management, Oakland, CA USA
[6] Kaiser Permanente Northern Calif, San Francisco, CA USA
[7] Kaiser Permanente Northern Calif, Walnut Creek, CA USA
[8] Kaiser Permanente, Pasadena, CA USA
[9] Kaiser Permanente, Oakland, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5588
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer
    Van Le, Linda
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (05) : 275 - 276
  • [2] Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
    Makker, V
    Colombo, N.
    Casado Herraez, A.
    Santin, A. D.
    Colomba, E.
    Miller, D. S.
    Fujiwara, K.
    Pignata, S.
    Baron-Hay, S.
    Ray-Coquard, I
    Shapira-Frommer, R.
    Ushijima, K.
    Sakata, J.
    Yonemori, K.
    Kim, Y. M.
    Guerra, E. M.
    Sanli, U. A.
    McCormack, M. M.
    Smith, A. D.
    Keefe, S.
    Bird, S.
    Dutta, L.
    Orlowski, R. J.
    Lorusso, D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05): : 437 - 448
  • [3] Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
    Makker, Vicky
    Taylor, Matthew H.
    Aghajanian, Carol
    Oaknin, Ana
    Mier, James
    Cohn, Allen L.
    Romeo, Margarita
    Bratos, Raquel
    Brose, Marcia S.
    DiSimone, Christopher
    Messing, Mark
    Stepan, Daniel E.
    Dutcus, Corina E.
    Wu, Jane
    Schmidt, Emmett V.
    Orlowski, Robert
    Sachdev, Pallavi
    Shumaker, Robert
    Casado Herraez, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 2981 - 2992
  • [4] Long term treatment of advanced endometrial cancer with lenvatinib and pembrolizumab
    Somasegar, Sahana
    Sousa, Becky
    Jairam-Thodla, Arati
    Dorigo, Oliver
    GYNECOLOGIC ONCOLOGY REPORTS, 2025, 58
  • [5] Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not
    Paulino, Eduardo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 579 - 579
  • [6] Lenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC)
    Makker, V.
    Taylor, M. H.
    Aghajanian, C.
    Oaknin, A.
    Mier, J.
    Cohn, A. L.
    Romeo Marin, M.
    Bratos Lorenzo, R.
    Brose, M. S.
    DiSimone, C.
    Messing, M. J.
    Stepan, D. E.
    Dutcus, C. E.
    Wu, J.
    Schmidt, E. V.
    Orlowski, R. J.
    Sachdev, P.
    Shumaker, R.
    Casado Herraez, A.
    ANNALS OF ONCOLOGY, 2019, 30 : 404 - +
  • [7] Lenvatinib plus Pembrolizumab in advanced Endometrial Carcinoma
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (05) : 464 - 464
  • [8] Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Updated results
    Makker, Vicky
    Rasco, Drew
    Vogelzang, Nicholas J.
    Messing, Mark
    Brose, Marcia S.
    Cohn, Allen L.
    Aghajanian, Carol
    Stepan, Daniel E.
    Dutcus, Corina
    Schmidt, Emmett
    Guo, Matthew
    Sachdev, Pallavi
    Shumaker, Robert
    Young, Louise
    Taylor, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 175 - 175
  • [9] Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab
    Pawsey, A.
    Mahalingam, P.
    Senthivel, N.
    Ramessur, A.
    Turnbull, E.
    Usman, S.
    Browne, R.
    Patel, A.
    Stewart, A.
    Tookman, L.
    Counsell, N.
    Miller, R.
    Nicum, S.
    Eminowicz, G.
    CLINICAL ONCOLOGY, 2025, 37
  • [10] A potential inflammatory biomarker for advanced endometrial cancer treated with lenvatinib plus pembrolizumab
    Yanazume, Shintaro
    Kobayashi, Yusuke
    Kirita, Yukari
    Kitazono, Ikumi
    Nagata, Chikako
    Kozai, Ayumi
    Tanimoto, Akihide
    Kobayashi, Hiroaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2025, 51 (01)
12345